Rockwell Medical (RMTI) Expected to Announce Quarterly Earnings on Thursday

Rockwell Medical (NASDAQ:RMTI) is anticipated to announce its earnings results before the market opens on Thursday, March 20th. Analysts expect the company to announce earnings of $0.02 per share and revenue of $23.65 million for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

Rockwell Medical Stock Up 7.9 %

RMTI opened at $1.64 on Thursday. The company has a current ratio of 2.41, a quick ratio of 2.00 and a debt-to-equity ratio of 0.33. Rockwell Medical has a 1-year low of $1.35 and a 1-year high of $5.15. The company has a market capitalization of $53.00 million, a PE ratio of -32.80 and a beta of 1.56. The firm’s 50 day simple moving average is $1.93 and its two-hundred day simple moving average is $2.67.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on RMTI. RODMAN&RENSHAW raised shares of Rockwell Medical to a “strong-buy” rating in a research note on Thursday, November 14th. Rodman & Renshaw began coverage on shares of Rockwell Medical in a research note on Thursday, November 14th. They issued a “buy” rating and a $5.00 price objective for the company. HC Wainwright reissued a “buy” rating and issued a $7.00 price objective on shares of Rockwell Medical in a research note on Monday, December 23rd. Finally, StockNews.com cut shares of Rockwell Medical from a “buy” rating to a “hold” rating in a research note on Friday, December 20th.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.